The Use of cf-DNA Testing for Rejection Surveillance in Heart Transplantation
Presented on: Tuesday, April 23, 2024
Until the past few years, several routine surveillance biopsies were needed for all patients following heart transplantation. Today, the use of cf-DNA testing has made frequent surveillance biopsies a thing of the past. This presentation will discuss one center’s journey and their results to significantly lower the number of post-heart transplant biopsies during the first year.
Discuss the use of cf-DNA testing in organ transplant rejection surveillance.
Review the advantages of using cf-DNA testing in heart transplantation.
Describe a rejection scoring system used to determine when to treat rejection.
Analyze the results of a center’s change in surveillance biopsy scheduling post-heart transplantation.
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.
